Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | GAA | P10253 | 4/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30902223 | 1.00 | TDP1 (0.61) | TDP1ALDH1A1GAAALOX15HTT | |
| SCHEMBL11175497 | 0.86 | GAA (0.49) | TDP1ALDH1A1GAAALOX15HTT | |
| SCHEMBL31244434 | 0.84 | MEN1 (0.58) | TDP1ALDH1A1GAAALOX15HTT | |
| SCHEMBL9630142 | 0.84 | MEN1 (0.58) | TDP1ALDH1A1GAAALOX15HTT | |
| SCHEMBL1686517 | 0.84 | TSHR (0.60) | TDP1ALDH1A1GAAHTTMEN1 | |
| SCHEMBL31498989 | 0.84 | TSHR (0.60) | TDP1ALDH1A1GAAHTTMEN1 | |
| SCHEMBL4544855 | 0.83 | TSHR (0.67) | GAAMEN1MAPTKMT2AMAPK1 | |
| SCHEMBL5542524 | 0.82 | TSHR (0.46) | TDP1ALDH1A1GAAALOX15HTT | |
| SCHEMBL10571549 | 0.82 | ADRA2A (0.68) | TDP1ALDH1A1GAAALOX15HTT | |
| SCHEMBL11125372 | 0.82 | MAPT (0.51) | TDP1ALDH1A1GAAALOX15HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118271158-B | Method for synthesizing deuterium-labeled substance containing deuterium atom structural unit | 山东大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-118271158-A | Method for synthesizing deuterium-labeled substance containing deuterium atom structural unit | 山东大学 | 2024-07-02 | — | — | CN | disclosed |
| CN-118063494-A | Organic electroluminescent compound with core structure of boron-containing polycyclic aza-aromatic hydrocarbon and application thereof | 吉林省元合电子材料有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-20230337537-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2023-10-19 | — | — | US | disclosed |
| US-20230337537-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2023-10-19 | — | — | US | disclosed |
| CN-115968393-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-113620811-B | Halogenation method of aromatic compound | 中国科学院兰州化学物理研究所 | 2022-05-24 | — | — | CN | disclosed |
| CN-113912621-A | Containing SO2Spiro pyrrolocarbazoles and application thereof | 北京云基科技有限公司 | 2022-01-11 | — | — | CN | disclosed |
| CN-113880854-A | Organic compound containing spiro furocarbazole structure and application thereof | 北京云基科技有限公司 | 2022-01-04 | — | — | CN | disclosed |
| CN-113880861-A | Containing SO2Spiro pyrrolocarbazoles compounds and application thereof | 北京云基科技有限公司 | 2022-01-04 | — | — | CN | disclosed |
| US-8173803-B2 | Supramolecular scaffolds and methods of making the same | LOYOLA UNIVERSITY OF CHICAGO (US) | 2012-05-08 | — | — | US | disclosed |
| US-7700595-B2 | such as 3-benzyl-4-phenyl-8-(trifluoromethyl)cinnoline; modulators of Liver X receptors (LXRs) | WYETH LLC (US) | 2010-04-20 | — | — | US | disclosed |
| US-20100041880-A1 | Supramolecular Scaffolds and Methods of Making the Same | LOYOLA UNIVERSITY OF CHICAGO (US) | 2010-02-18 | — | — | US | disclosed |
| CN-101166730-A | Cinnoline compounds and their use as liver X receptor modilators | WYETH CORP (US) | 2008-04-23 | — | — | CN | disclosed |
| EP-1853566-A1 | CINNOLINE COMPOUNDS AND THEIR USE AS LIVER X RECEPTOR MODULATORS | Wyeth (US) | 2007-11-14 | — | — | EP | disclosed |
| US-20060252757-A1 | Cinnoline compounds | WYETH | 2006-11-09 | — | — | US | disclosed |
| WO-2006094034-A1 | CINNOLINE COMPOUNDS AND THEIR USE AS LIVER X RECEPTOR MODILATORS | WYETH (US) | 2006-09-08 | — | — | WO | disclosed |
| US-7011699-B2 | Inkjet ink, inkjet recording method and production method of inkjet ink | FUJI PHOTO FILM CO., LTD. (JP) | 2006-03-14 | — | — | US | disclosed |
| US-20040106700-A1 | Inkjet ink, inkjet recording method and production method of inkjet ink | FUJI PHOTO FILM CO., LTD. | 2004-06-03 | — | — | US | disclosed |
| US-4362893-A | Preparation of C-nitrosodiarylamines from diarylamines | UOP INC. (US) | 1982-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337537-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | L1CAM, PIEZO1, GPX1 | TDP1 1247/4885ALDH1A1 34/4885GAA 2508/4885 |
| US-20060252757-A1 | Cinnoline compounds | NR1H3, NR1H2, CNR1 | TDP1 4009/4885ALDH1A1 938/4885GAA 2674/4885 |
| US-20100041880-A1 | Supramolecular Scaffolds and Methods of Making the Same | BLM, TBXAS1, TOP2B | TDP1 554/4885ALDH1A1 1363/4885GAA 3447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.